| Novel approaches to hemophilia therapy: successes and challenges VR Arruda, BS Doshi, BJ Samelson-Jones Blood, The Journal of the American Society of Hematology 130 (21), 2251-2256, 2017 | 129 | 2017 |
| Gene therapy for hemophilia: what does the future hold? BS Doshi, VR Arruda Therapeutic advances in hematology 9 (9), 273-293, 2018 | 125 | 2018 |
| A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function SL Meeks, CL Cox, JF Healey, ET Parker, BS Doshi, B Gangadharan, ... Blood, The Journal of the American Society of Hematology 120 (12), 2512-2520, 2012 | 55 | 2012 |
| Acquired hemophilia A: current guidance and experience from clinical practice AM Pishko, BS Doshi Journal of blood medicine, 255-265, 2022 | 42 | 2022 |
| Emerging therapies for hemophilia: controversies and unanswered questions VR Arruda, BS Doshi, BJ Samelson-Jones F1000Research 7, 2018 | 41 | 2018 |
| Gene therapy for hemophilia: Progress to date and challenges moving forward KL Gollomp, BS Doshi, VR Arruda Transfusion and Apheresis Science 58 (5), 602-612, 2019 | 38 | 2019 |
| Gene therapy for hemophilia: facts and quandaries in the 21st century VR Arruda, BS Doshi Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020 | 25 | 2020 |
| Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients BS Doshi, RS Rogers, HB Whitworth, EA Stabnick, J Britton, RB Butler, ... Journal of Thrombosis and Haemostasis 17 (11), 1838-1847, 2019 | 25 | 2019 |
| B cell–activating factor modulates the factor VIII immune response in hemophilia A BS Doshi, J Rana, G Castaman, MA Shaheen, R Kaczmarek, ... The Journal of Clinical Investigation 131 (8), 2021 | 24 | 2021 |
| Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition BS Doshi, B Gangadharan, CB Doering, SL Meeks PLoS One 7 (10), e48172, 2012 | 19 | 2012 |
| Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors BS Doshi, LJ Raffini, LA George Journal of Thrombosis and Haemostasis 18 (4), 848-852, 2020 | 13 | 2020 |
| Recurrence of a high‐titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis. BS Doshi, CM Witmer Haemophilia 27 (4), 2021 | 10 | 2021 |
| AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life BS Doshi, BJ Samelson-Jones, TC Nichols, EP Merricks, JL Siner, ... Molecular Therapy Methods & Clinical Development 32 (1), 2024 | 7 | 2024 |
| Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature BS Doshi, C Abramowsky, M Briones, ST Bunting American Journal of Blood Research 4 (1), 41, 2014 | 7 | 2014 |
| Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog L Van Gorder, BS Doshi, E Willis, TC Nichols, E Cook, JK Everett, ... Molecular Therapy Methods & Clinical Development 31, 2023 | 6 | 2023 |
| Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo W Cao, AR Trask, AI Bignotti, LA George, BS Doshi, DE Sabatino, N Yada, ... Journal of Thrombosis and Haemostasis 21 (12), 3477-3489, 2023 | 4 | 2023 |
| Vector Analysis of Multicentric Lymphoma in a Severe Hemophilia Α Dog after AAV Gene Therapy L Van Gorder, BS Doshi, E Willis, M Lanza, VR Arruda, MB Callan, ... Blood 140 (Supplement 1), 4919-4920, 2022 | 3 | 2022 |
| Coagulopathy predicts mortality in pediatric patients with traumatic brain injury BS Doshi, SL Meeks, JE Hendrickson, A Reisner, T Leong, AM Winkler, ... Blood 124 (21), 2891, 2014 | 3 | 2014 |
| Coagulation factor VIII: biological basis of emerging hemophilia A therapies BJ Samelson-Jones, BS Doshi, LA George Blood 144 (21), 2185-2197, 2024 | 1 | 2024 |
| Hemolysis After Medication Exposure in Pediatric Patients With G6PD Deficiency BS Doshi, A Kamdar, MP Lambert, AE Obstfeld Journal of Pediatric Hematology/Oncology 44 (5), 261-263, 2022 | 1 | 2022 |
